GGrantIndex
← Search

CORE--TRANSGENIC ANIMAL FACILITY

$0P30FY2001CANIH

Northwestern University, Evanston IL

Investigators

Linked publications, trials & patents

Trial NCT07639528Trial NCT07594626Trial NCT07594548Trial NCT07290543Trial NCT07261657Trial NCT07178301Trial NCT07169617Trial NCT07050186Trial NCT07042919Trial NCT06959641Trial NCT06813898Trial NCT06723457Trial NCT06630416Trial NCT06571734Trial NCT06499870Trial NCT06410248Trial NCT06327477Trial NCT06247540Trial NCT06244004Trial NCT06242834Trial NCT06184750Trial NCT06164275Trial NCT06137651Trial NCT06062498Trial NCT06060587Trial NCT06022822Trial NCT05879250Trial NCT05852041Trial NCT05802186Trial NCT05744739Trial NCT05733000Trial NCT05620771Trial NCT05576896Trial NCT05545150Trial NCT05453799Trial NCT05419011Trial NCT05411107Trial NCT05236036Trial NCT05202782Trial NCT05093387Trial NCT04931017Trial NCT04910425Trial NCT04795869Trial NCT04767984Trial NCT04753216Trial NCT04576104Trial NCT04550481Trial NCT04250051Trial NCT04227028Trial NCT04200443Trial NCT04049227Trial NCT04047706Trial NCT04033432Trial NCT04009044Trial NCT03854474Trial NCT03812562Trial NCT03742258Trial NCT03723915Trial NCT03704714Trial NCT03513484Trial NCT03317405Trial NCT03278925Trial NCT03226249Trial NCT03213041Trial NCT03146650Trial NCT03077828Trial NCT03070002Trial NCT03061188Trial NCT03048500Trial NCT03044730Trial NCT03036930Trial NCT03020017Trial NCT02993159Trial NCT02968810Trial NCT02965703Trial NCT02901899Trial NCT02892734Trial NCT02871323Trial NCT02861040Trial NCT02847559Trial NCT02837029Trial NCT02819804Trial NCT02808143Trial NCT02805868Trial NCT02794883Trial NCT02774681Trial NCT02743364Trial NCT02720484Trial NCT02694809Trial NCT02536794Trial NCT02530619Trial NCT02530502Trial NCT02530125Trial NCT02481310Trial NCT02365480Trial NCT02357810Trial NCT02314156Trial NCT02242097Trial NCT02237183Trial NCT02232516

Abstract

DESCRIPTION (provided by applicant): The Northwestern University Transgenic Core Facility is a well established, university-wide resource designed for the production of transgenic and knock-out animals for investigators of the Cancer Center, Northwestern University Medical School, Northwestern University and other affiliated institutions. Since it?s inception in 1989 as part of the Markey Program in Developmental Biology, the facility has grown steadily creating a myriad of transgenic mouse lines by pronuclear microinjection for NU investigators. Relocated in March of 1996 to Children?s Memorial Institute for Education and Research, the facility within the last few years has also been successful at creating knock-out mice for several investigators. The facility serves as a nuclear framework equipped with expensive microinjection apparatus and staffed with technically skilled individuals with expertise in microinjection, microsurgeries, embryo manipulation, cell culture and animal husbandry. Providing these services necessitates the maintenance of a large and costly animal colony. Animals are housed in state of the art caging systems to maintain a specific pathogen free level of health status allowing for their transfer readily into other animal facilities. Other services provided by the facility that take advantage of both the facility?s large stock colony and technical expertise include in vitro fertilization for rederivation or fertilization studies; embryo rederivation; breeding; and preparation of foster or timed-pregnant females. In addition, facility personnel provide consultation on all aspects of trangenesis ranging from initially seeking IACUC approval to breeding and analysis of newly created transgenic or knock-out mice. The Transgenic Core facility has a superb oversight committee which meets quarterly and is composed of faculty members from all three NU campuses. Over the last five years, the primary group of NU investigators benefiting from this shared resource have been Cancer Center members accounting for greater than 70% of the total usage. The potential to generate transgenic and knock-out animals in a timely and costly manner is critical and is an essential component of this core facility.

View original record on NIH RePORTER →